Eva Forssell‐Aronsson

Author

Also Known As

E B Forssell-Aronsson, E FORSSELL-ARONSSON, E Forssell-Aronsson, E. Forssell Aronsson, E. Forssell-Aronsson, E. Forssell-aronsson, E. Forssell‐Aronsson, EVA FORSSELL‐ARONSSON, Eva B. Forssell-Aronsson, Eva Forsell Aronsson

280

Publications

5.2K

Citations

H-Index

128

Concepts

All Affiliations

Sahlgrenska University Hospital University of Gothenburg Lund University

About

Eva Forssell‐Aronsson is an author at Sahlgrenska University Hospital specializing in medicine, nuclear medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	34	1.2K
2	Health Sciences	12	13	516
3	Engineering	10	11	247
4	Natural Sciences	1	1	28
5	Social Sciences	1	1	90

Eva Forssell‐Aronsson

124

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Specific Growth Rate versus Doubling Time for Quantitative Characterization of Tumor Growth Rate Esmaeil Mehrara, Eva Forssell‐Aronsson, Håkan Ahlman, Cancer Research	2007	237
Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens Peter Larsson, Hanna Engqvist, Jana Biermann, Scientific Reports	2020	209
A Transplantable Human Carcinoid as Model for Somatostatin Receptor-Mediated and Amine Transporter-Mediated Radionuclide Uptake Lars Kölby, Peter Bernhardt, Håkan Ahlman, American Journal Of Pathology Oncogenic AgentMedicineRadionuclide TherapyPharmacologyPathology	2001	118
Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours Ola Nilsson, Lars Kölby, Bo Wängberg, British Journal of Cancer Somatic VariantEndocrine-related CancerSomatostatin Receptor SubtypesOctreotide ScintigraphyMedicine	1998	109
Renal function affects absorbed dose to the kidneys and haematological toxicity during 177Lu-DOTATATE treatment Johanna Svensson, Gertrud E. B. Berg, Bo Wängberg, European Journal of Nuclear Medicine and Molecular Imaging	2015	108
Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters Lars Kölby, Peter Bernhardt, A-M Levin-Jakobsen, British Journal of Cancer	2003	105
111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors. Eva Forssell‐Aronsson, Ola Nilsson, S A Bejegård, PubMed	2000	93
A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity Göran Starck, Maria Ljungberg, Marie K. L. Nilsson, Journal of Neural Transmission PsychiatryAddictionObsessive Compulsive DisorderObsessive-compulsive DisorderPsychopharmacology	2008	90
A method to obtain the same levels of CT image noise for patients of various sizes, to minimize radiation dose Göran Starck, Lars Lönn, Åke Cederblad, British Journal of Radiology Computed TomographyTreatment VerificationRadiation TestingRadiographyNoise	2002	90
Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide. P. Andersson, Eva Forssell‐Aronsson, Viktor Johanson, PubMed	1996	88

Page 1